ADIM
ACHC icon

Alpha DNA Investment Management’s Acadia Healthcare ACHC Stock Holding History

Alpha DNA Investment Management’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25
Closed -$1K – 105
2021
Q1 		$1K Buy
+25
New +$1.35K ﹤0.01% 601

Other funds holding ACHC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Alpha DNA Investment Management's ACHC Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Acadia Healthcare (ACHC) in Q2 2021, closing a stake of 25 shares — an estimated $1K sold.

Alpha DNA Investment Management first reported a position in ACHC in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 285 funds tracked by Wall St. Rank hold ACHC as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Acadia Healthcare position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 25 Acadia Healthcare shares in Q2 2021, an estimated $1K.
  • Alpha DNA Investment Management first reported a position in Acadia Healthcare in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Acadia Healthcare position peaked at $1K in Q1 2021.
  • 285 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.